EUVIMEDEUVIMED entdecken
Open Access

Implementation Determinants of HIV Testing and Pre-Exposure Prophylaxis in Community Pharmacies in Philadelphia, PA

Cedric H Bien-Gund iD, Anna Sweeney, Brandon Ptak iD, Michelle Jeon, David Koren iD, Javontae Williams, Kathleen A Brady, Jose Bauermeister, Sarah M Wood

AIDS Patient Care and STDs · 2025-09 · 39 (9) · 353-362

DOI: 10.1177/10872914251365540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS Patient Care and STDs, online erschienen am 26.08.2025. Verfasst von Cedric H Bien-Gund und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: HIV Infections, Pre-Exposure Prophylaxis, HIV Testing, Community Pharmacy Services. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Delivering HIV testing and pre-exposure prophylaxis (PrEP) in community pharmacies can expand access to HIV services for populations with limited access to care. However, few pharmacies in the United States have successfully implemented these services. We investigated implementation barriers and facilitators of pharmacy-based HIV testing and PrEP initiation in Philadelphia, an Ending the HIV Epidemic priority jurisdiction with high rates of HIV and bacterial STIs, located in a state with relatively restrictive laws governing pharmacy scope of practice. Using a sequential, exploratory mixed-methods study design, we conducted 15 in-depth interviews with pharmacists and key implementing partners, followed by an online survey of pharmacists, pharmacy students, and technicians ( n = 59). Interviews and surveys were analyzed using the Consolidated Framework for Implementation Research. Data were collected from October 31, 2023, to October 17, 2024. Interviewees representing three pharmacy sites had initiated HIV testing, but no sites had yet successfully implemented pharmacy-based PrEP. The primary barriers to delivering HIV testing were based on inner setting barriers (existing work burden, overly complex protocols). Legal restrictions and reimbursement concerns were the primary barriers to implementing pharmacy-based PrEP. Participants described potential solutions and mitigating strategies to these barriers, such as collaborative practice agreements and developing standing orders with medical providers, integration with telePrEP models, streamlined blueprints and protocols, and practice-based champions. Survey respondents indicated high levels of acceptability but lower levels of perceived implementation feasibility. To optimize implementation sustainability and success, implementation strategies need to adequately address legal barriers and reimbursement concerns and be integrated into the pharmacy workflow.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPre-Exposure ProphylaxisHIV TestingCommunity Pharmacy ServicesAnti-HIV AgentsPharmaciesHumansPhiladelphiaPharmacistsFemaleMaleSurveys and QuestionnairesInterviews as TopicHealth Services AccessibilityAdult

Stichwörter der Autor:innen

Consolidated Framework for Implementation ResearchHIV preventionHIV testingimplementation determinantspharmacypre-exposure prophylaxis

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Center for Clinical Epidemiology and Biostatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • School of Health Professions, Philadelphia College of Pharmacy, Saint Joseph's University, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Cedric H Bien-Gund, Brandon Ptak, David Koren

Förderung

  • NIMH NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Bien-Gund, C. H., Sweeney, A., Ptak, B., Jeon, M., Koren, D., Williams, J., Brady, K. A., Bauermeister, J., & Wood, S. M. (2025). Implementation Determinants of HIV Testing and Pre-Exposure Prophylaxis in Community Pharmacies in Philadelphia, PA. AIDS Patient Care and STDs, 39(9), 353-362. https://doi.org/10.1177/10872914251365540

Vancouver

Bien-Gund CH, Sweeney A, Ptak B, Jeon M, Koren D, Williams J, et al. Implementation Determinants of HIV Testing and Pre-Exposure Prophylaxis in Community Pharmacies in Philadelphia, PA. AIDS Patient Care and STDs. 2025;39(9):353-362. doi:10.1177/10872914251365540

BibTeX
@article{BienGund2025,
  author = {Bien-Gund, Cedric H and Sweeney, Anna and Ptak, Brandon and Jeon, Michelle and Koren, David and Williams, Javontae and Brady, Kathleen A and Bauermeister, Jose and Wood, Sarah M},
  title = {Implementation Determinants of HIV Testing and Pre-Exposure Prophylaxis in Community Pharmacies in Philadelphia, PA},
  journal = {AIDS Patient Care and STDs},
  year = {2025},
  volume = {39},
  number = {9},
  pages = {353--362},
  doi = {10.1177/10872914251365540}
}
Kostenlos starten →